A comparison of hepatitis B seroepidemiology in ten European countries
- 23 December 2008
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 137 (7), 961-969
- https://doi.org/10.1017/s0950268808001672
Abstract
SUMMARY: To inform current and future vaccination strategies, we describe the seroepidemiology of hepatitis B virus (HBV) infection in ten representative European countries using standardized serology that allowed international comparisons. Between 1996 and 2003, national serum banks were compiled by collecting residual sera or by community sampling; sera were then tested by each country using its preferred enzyme immunoassays and testing algorithm, and assay results were standardized. Information on current and past HBV vaccination programmes in each country was also collected. Of the ten countries, six reported low levels (<3%) of antibodies against HBV core antigen (anti-HBc). Of the eight countries testing for HBV surface antigen (HBsAg), the highest prevalence was reported in Romania (5·6%) and in the remaining seven countries prevalence was <1%. Universal HBV vaccination programmes had been established in seven countries as recommended by the World Health Organization, but the seroprevalence of antibodies against HBsAg (anti-HBs) was lower than the reported vaccine coverage in three countries. Regular serological surveys to ascertain HBV status within a population, such as reported here, provide important data to assess the need for and to evaluate universal HBV vaccination programmes.Keywords
This publication has 30 references indexed in Scilit:
- The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European regionVaccine, 2007
- Molecular Testing in the Diagnosis and Management of Chronic Hepatitis BClinical Microbiology Reviews, 2007
- Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?The Lancet Infectious Diseases, 2007
- The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virusJournal of Viral Hepatitis, 2006
- Hepatitis B immunisation in Britain: time to change?BMJ, 2006
- Response to Hepatitis B Vaccine in HIV‐1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine StrategiesThe Journal of Infectious Diseases, 2005
- Hepatitis B vaccination in a school age population: a feasibility studyJournal of Medical Virology, 2005
- Hepatitis B control in Europe by universal vaccination programmes: The situation in 2001Journal of Medical Virology, 2002
- Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989–1996Vaccine, 2000
- Overview of epidemiology and disease burden of hepatitis B in the European regionVaccine, 1995